OR WAIT null SECS
© 2022 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
August 01, 2022
Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
July 29, 2022
Arcutis Biotherapeutics’ roflumilast cream will provide relief to patients aged 12 years or older diagnosed with plaque psoriasis.
July 22, 2022
Stephen Stripling, MD, FAAP, discusses results published in JAMA Dermatology about the efficacy and safety of berdazimer gel 10.3% for the treatment of molluscum contagiosum.
July 19, 2022
Opzelura (ruxolitinib) cream is the first and only FDA-approved treatment for adult and pediatric patients 12 years of age or older with vitiligo.
July 07, 2022
Cynthia J. Trickett, PA-C, MPAS, discusses the personal and clinical effects of atopic dermatitis in adult and pediatric patients at the 2022 Maui Dermatology Conference for PAs & NPs.
July 06, 2022
Verrica is complying with the FDA through 3 Complete Response Letters to achieve the first FDA-approved treatment of molluscum contagiosum.